PHILADELPHIA (April 24, 2020) – Christian Koch, MD, PhD, FACP, MACE, a professor in the Department of Medicine and director for the Division of Endocrinology at Fox Chase Cancer Center, was recently named a review editor for Frontiers in Cancer Endocrinology, a specialty section in the journal Frontiers in Endocrinology.

PHILADELPHIA (April 21, 2020)—A clinical trial headed by Fox Chase Cancer Center physicians has found that patients with certain common benign, spontaneous kidney tumors saw a marked decrease in tumor volume after being treated with the drug everolimus, also known by its brand name, Afinitor. Until this study, there were no data on whether the drug was effective and safe for patients with the tumors who don’t have angiomyolipomas.

PHILADELPHIA (April 17, 2020) — A  $2.3 million grant for a multicenter randomized clinical trial to study the use of medically tailored meals and individually-tailored nutrition counseling as part of care for lung cancer patients will enroll 150 newly diagnosed stage I-IV lung cancer patients from vulnerable populations, including those who are uninsured, economically disadvantaged, older adults, rural residents or racial/ethnic minorities.